Citation Impact
Citing Papers
A Molecular Taxonomy for Urothelial Carcinoma
2012
MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
2010
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
2014
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation
2020 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature
2006
Delayed graft function in kidney transplantation
2004 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Executive Leadership and Physician Well-being
2016 Standout
Manipulation of the nerve growth factor network in prostate cancer
2007
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Improved peak detection and quantification of mass spectrometry data acquired from surface‐enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform
2005
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation
2006
Discovery of Urinary Biomarkers
2006
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study
2008
Epidemiology of Prostate Cancer
2019 Standout
Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
2011
Cisplatin Nephrotoxicity: A Review
2007 Standout
Acute Renal Failure
1996 Standout
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry
2005
Functional protease profiling for diagnosis of malignant disease
2011
Matrix Metalloproteinases and Other Matrix Proteinases in Relation to Cariology: The Era of ‘Dentin Degradomics'
2015 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
2002 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Exosomes – vesicular carriers for intercellular communication
2009 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Serum proteomics profiling—a young technology begins to mature
2005
Why we are wasting time in the operating theatre?
2008
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Epidemiology and genetic susceptibility to bladder cancer
2008
Bladder acellular matrix as a substrate for studying in vitro bladder smooth muscle–urothelial cell interactions
2004
A rapid MALDI-TOF mass spectrometry workflow for Drosophila melanogaster differential neuropeptidomics
2013 StandoutNobel
Effect of perioperative inefficiency on neurosurgical theatre efficacy: A 15-year analysis
2015
Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk
2011
Analysis of acute‐phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer
2011
Processing and classification of protein mass spectra
2006
Single luminal epithelial progenitors can generate prostate organoids in culture
2014
Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells
2008
Cholesterol crystal embolism: A recognizable cause of renal disease
2000
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Modeling Development and Disease with Organoids
2016 Standout
Perineural invasion in cancer
2009 Standout
Polymorphisms in the DNA Repair GenesXPC, XPD, andXPGand Risk of Cutaneous Melanoma: a Case-Control Analysis
2006
Tumour stem cells and drug resistance
2005 Standout
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
2011
Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.
2002
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Bladder Cancer
2020 Standout
The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation
2008
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
CD133, a novel marker for human prostatic epithelial stem cells
2004
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Approaches to Modeling Stromal-Epithelial Interactions
2002
Identification of Pancreatic Cancer Stem Cells
2007 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Classification algorithms for phenotype prediction in genomics and proteomics
2007
What is principal component analysis?
2008 Standout
Estrogen-Initiated Transformation of Prostate Epithelium Derived from Normal Human Prostate Stem-Progenitor Cells
2011
Cancer treatment and survivorship statistics, 2019
2019 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
A review of feature selection techniques in bioinformatics
2007 Standout
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
2005 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Alan Paul being referenced
Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer
2010
The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder
2005
Expression of NRG1 and its receptors in human bladder cancer
2011
DNA repair gene XRCC1 polymorphisms and bladder cancer risk
2007
Similar Treatment Outcomes for Radical Cystectomy and Radical Radiotherapy in Invasive Bladder Cancer Treated at a United Kingdom Specialist Treatment Center
2007
Low-affinity nerve growth factor receptors (p75 LNGFR ) in human prostate tissue: stromal localisation
1998
The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer
1994
The diagnostic yield of intravenous urography: a demographic study
1994
Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.
2003
Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture.
2001
APE1 and XRCC1 Protein Expression Levels Predict Cancer-Specific Survival Following Radical Radiotherapy in Bladder Cancer
2005
Primary non-function of a renal allograft due to atheromatous emboli
1994
An audit of the usage of operating theatre time in a peripheral teaching surgical unit
1990
AN INTEGRATED HAEMATURIA CLINIC
1993
Comprehensive Analysis of 22XPCPolymorphisms and Bladder Cancer Risk
2006